Citoneurin

Citoneurin is a vitamin supplement that combines thiamine hydrochloride, cyanocobalamin, and pyridoxine hydrochloride. It is formulated for intramuscular injection and is marketed in the European Union. The product provides essential B‑vitamins (B1, B6, B12) that serve as co‑enzymes in carbohydrate and amino‑acid metabolism and support red‑blood‑cell formation. It is intended for use to correct or prevent deficiencies of the listed B‑vitamins.

Citoneurin is indicated for several nutritional and clinical situations where B‑vitamin levels are insufficient.

- Treatment of thiamine (vitamin B1) deficiency. - Treatment of pyridoxine (vitamin B6) deficiency. - Treatment of cyanocobalamin (vitamin B12) deficiency. - Support of general nutritional status in individuals with increased metabolic demand. - Adjunct therapy in conditions associated with anemia or neuropathy related to B‑vitamin deficits.

Side‑effect profiles for intramuscular B‑vitamin complexes are generally mild, but reactions can vary among individuals.

Common: - Mild pain or irritation at the injection site. - Transient flushing or warmth. - Low‑grade fever. - Headache.

Serious: - Severe allergic reaction (anaphylaxis) with difficulty breathing. - Rapid heart rate or palpitations. - Persistent hypotension.

When considering Citoneurin, healthcare providers should evaluate patient history and specific clinical factors.

- Avoid use in individuals with known hypersensitivity to any B‑vitamin component. - Assess renal or hepatic impairment before administration, as metabolism may be altered. - Use caution in pregnant or breastfeeding women; benefits should outweigh potential risks. - Monitor patients with a history of cardiovascular disease for possible tachycardia. - Do not exceed recommended dosing intervals without medical guidance. - Consider baseline vitamin B12 levels to prevent masking of underlying deficiencies.

Citoneurin may interact with certain medications; awareness of these interactions helps prevent adverse outcomes.

Avoid: - Concurrent use of high‑dose vitamin B6 with levodopa, which may reduce levodopa efficacy. - Simultaneous administration with nitrous oxide anesthesia, which can inactivate vitamin B12.

Use with caution: - Metformin therapy, which may lower vitamin B12 absorption; monitor levels. - Anticonvulsants such as phenytoin or carbamazepine, which can affect vitamin B6 status. - Oral contraceptives, which may alter vitamin B6 metabolism.